On-X Life Technologies, Inc.

36 articles about On-X Life Technologies, Inc.

• CryoLife Agrees to Acquire On-X Life Technologies for $130 Million

  12/23/2015

• On-X Life Technologies, Inc. To Launch Chord-X Mitral Valve Chordal Repair System

  5/20/2015

• Cardiothoracic Clinicians To Examine Benefits Of Reducing On-X Life Technologies, Inc. Aortic Valve Patients’ Warfarin Regimen At AATS

  4/28/2015

• On-X Life Technologies, Inc. Release: FDA Approval: On-X Aortic Valves With Less Warfarin

  4/6/2015

• On-X Life Technologies, Inc. To Launch Chord-X™ Mitral Valve Chordal Repair System At Society Of Thoracic Surgeons (STS) San Diego

  1/22/2015

• On-X Life Technologies, Inc. Produces Heart Valve Components For SynCardia Systems, Inc. Total Artificial Heart

  8/25/2014

• On-X Life Technologies, Inc. To Present Its Newest Advance In Heart Valve Technology At “94th Annual Scientific Meeting” Of The American Association For Thoracic Surgery (AATS) In Toronto

  4/24/2014

• 50-Year Retrospective Study Shows On-X Life Technologies, Inc.’ Mechanical Heart Valves Have “The Lowest Incidence Of Valve Thrombosis”

  4/4/2014

• On-X Life Technologies, Inc. To Present Its Newest Advance In Heart Valve Technology At The Asian Society For Cardiovascular And Thoracic Surgery (ASCVTS) In Istanbul, Turkey

  4/2/2014

• On-X Life Technologies, Inc. Begins Shipping Its On-X® Plus 1.5™ Aortic Heart Valve To European Hospitals

  3/31/2014

• On-X Life Technologies, Inc. Prepares European Sales Force To Sell On-X® Plus 1.5™ Aortic Heart Valve

  3/18/2014

• On-X Life Technologies, Inc. To Launch Its On-X® Plus 1.5™ Aortic Heart Valve At Annual Meeting Of The Society For Cardiothoracic Surgery (SCS) In Great Britain & Ireland

  3/6/2014

• On-X Life Technologies, Inc. Reports CE Mark Approval To Sell Its Mechanical Aortic Heart Valve With An Expanded Labeling Claim: A Reduction In The Required Use Of Blood Thinners

  1/15/2014

• On-X Life Technologies, Inc. Release: EACTS Report - Prospective Randomized On-X Heart Valve Clinical Trial (PROACT) Provides Evidence of Reduced Complications

  10/7/2013

• On-X Life Technologies, Inc. Release: Economic Model of the Life-time Cost Impact of Heart Valve Prosthetic Choice to be Presented at ISPOR Meeting

  5/21/2013

• Enrollment Completed for Low-Risk Aortic and Mitral Patient Groups For On-X Life Technologies, Inc.® Prosthetic Heart Valve Anticoagulation Clinical Study

  5/7/2013

• AATS Report: Prospective Randomized On-X Life Technologies, Inc. Heart Valve Clinical Trial (PROACT) Provides Evidence of Reduced Complications

  5/7/2013

• On-X Life Technologies, Inc. Release: Story Predicting Long-Term Costs of Heart Valve Replacement Study to be Presented at American College of Cardiology Meeting

  3/8/2013

• On-X Life Technologies, Inc. Receives FDA Approval for On-X Heart Valve With Anatomic Shaped Sewing Ring

  2/26/2013

• On-X Life Technologies, Inc. Submits for FDA/CE Approval of Reduced Anticoagulation Indication for On-X Aortic Heart Valve

  10/22/2012